Enteral Syringe Market By Type (Reusable, Disposable), By Age Group (Adults, Pediatrics) By End User (Hospitals, Ambulatory Surgical Centers, Homecare) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

The global enteral syringe market was valued at $383.6 million in 2023, and is projected to reach $643.6 million by 2033, growing at a CAGR of 5.3% from 2024 to 2033.

An enteral syringe is a specialized medical device used for administering liquid medications, nutrients, or fluids directly into the gastrointestinal tract, typically through a feeding tube. This syringe is specifically designed with features such as accurate volume measurement, compatibility with enteral feeding tubes, and safety mechanisms to prevent accidental disconnection or leakage.

The growth of the enteral syringe market is driven by poverty, inadequate access to nutritious food, chronic illnesses, and aging populations contribute to the rising incidence of malnutrition cases. Enteral syringes play a crucial role in delivering essential nutrients directly into the gastrointestinal tract, ensuring patients receive adequate nutrition when oral intake is insufficient or not feasible. Moreover, rise in the trend toward home healthcare is driving the market forward. With the rise in the number of patients seeking enteral medication and nutrition at home rather than admitted to hospitals, the demand for user-friendly enteral syringes is growing. Thus, manufacturers are producing syringes that are easy to use and set compatible with home enteral feeding equipment.

However, stringent governmental regulations pose a restraint to the growth of the market growth. Regulatory authorities impose strict standards and approval processes for medical devices, including enteral syringes, to ensure safety, efficacy, and quality. Contrarily, the development of advanced feeding devices with lesser side effects presents an opportunity for the growth of the market. Innovations in enteral syringe design, materials, and functionalities aim to enhance patient comfort, reduce complications, and improve treatment outcomes. For instance, the development of enteral syringes, by Baxter International Inc., with ergonomic designs, precise dosage control mechanisms, and anti-reflux features can minimize the risk of aspiration and tube-related complications, making enteral feeding safer and more efficient.

Segmentation Overview

The enteral syringe market is segmented into type, age group, end user, and region. Depending on the type, the market is bifurcated into reusable and disposable. According to age group, it is divided into adults and pediatrics. According to end user, the market is classified into hospitals, ambulatory surgical centers (ASCS), and home care. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive Scenario

The major players operating in the enteral syringe market include Fresenius SE & Co. KGaA, Boston Scientific Corporation, Danone, Cook Medical, Inc., Cardinal Health Inc., Becton, Dickinson and Company, Moog Inc., B. Braun Melsungen AG, Owens & Minor, Inc., and Nestle S.A. Other players in the enteral syringe market include Medtronic PLC, Medline Industries LP, Kentec Medical Inc., Thermo Fisher Scientific Inc, and Baxter International Inc. These players have employed several strategies such as mergers & acquisitions, partnerships, collaboration, and continuous product development and innovation to strengthen their position in the competitive environment.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Type

Reusable
Disposable

By Age Group

Adults
Pediatrics

By End User

Hospitals
Ambulatory Surgical Centers
Homecare

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Fresenius SE & Co. KGaA
Boston Scientific Corporation
Danone
Cook Medical, Inc.
Cardinal Health Inc.
Becton, Dickinson and Company
Moog Inc.
B. Braun Melsungen AG
Owens & Minor, Inc.
Nestle S.A.

Product Code: A200746

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities

CHAPTER 4: ENTERAL SYRINGE MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Reusable
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Disposable
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5: ENTERAL SYRINGE MARKET, BY AGE GROUP

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Age Group
5.2. Adults
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Pediatrics
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country

CHAPTER 6: ENTERAL SYRINGE MARKET, BY END USER

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3. Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4. Homecare
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country

CHAPTER 7: ENTERAL SYRINGE MARKET, BY REGION

7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Age Group
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Enteral Syringe Market
  - 7.2.6.1. Market Size and Forecast, By Type
  - 7.2.6.2. Market Size and Forecast, By Age Group
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Enteral Syringe Market
  - 7.2.7.1. Market Size and Forecast, By Type
  - 7.2.7.2. Market Size and Forecast, By Age Group
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Enteral Syringe Market
  - 7.2.8.1. Market Size and Forecast, By Type
  - 7.2.8.2. Market Size and Forecast, By Age Group
  - 7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Age Group
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Enteral Syringe Market
  - 7.3.6.1. Market Size and Forecast, By Type
  - 7.3.6.2. Market Size and Forecast, By Age Group
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Enteral Syringe Market
  - 7.3.7.1. Market Size and Forecast, By Type
  - 7.3.7.2. Market Size and Forecast, By Age Group
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Enteral Syringe Market
  - 7.3.8.1. Market Size and Forecast, By Type
  - 7.3.8.2. Market Size and Forecast, By Age Group
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Enteral Syringe Market
  - 7.3.9.1. Market Size and Forecast, By Type
  - 7.3.9.2. Market Size and Forecast, By Age Group
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Enteral Syringe Market
  - 7.3.10.1. Market Size and Forecast, By Type
  - 7.3.10.2. Market Size and Forecast, By Age Group
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest of Europe Enteral Syringe Market
  - 7.3.11.1. Market Size and Forecast, By Type
  - 7.3.11.2. Market Size and Forecast, By Age Group
  - 7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Age Group
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Enteral Syringe Market
  - 7.4.6.1. Market Size and Forecast, By Type
  - 7.4.6.2. Market Size and Forecast, By Age Group
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Enteral Syringe Market
  - 7.4.7.1. Market Size and Forecast, By Type
  - 7.4.7.2. Market Size and Forecast, By Age Group
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Enteral Syringe Market
  - 7.4.8.1. Market Size and Forecast, By Type
  - 7.4.8.2. Market Size and Forecast, By Age Group
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Enteral Syringe Market
  - 7.4.9.1. Market Size and Forecast, By Type
  - 7.4.9.2. Market Size and Forecast, By Age Group
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Enteral Syringe Market
  - 7.4.10.1. Market Size and Forecast, By Type
  - 7.4.10.2. Market Size and Forecast, By Age Group
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Enteral Syringe Market
  - 7.4.11.1. Market Size and Forecast, By Type
  - 7.4.11.2. Market Size and Forecast, By Age Group
  - 7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Age Group
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Enteral Syringe Market
  - 7.5.6.1. Market Size and Forecast, By Type
  - 7.5.6.2. Market Size and Forecast, By Age Group
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Enteral Syringe Market
  - 7.5.7.1. Market Size and Forecast, By Type
  - 7.5.7.2. Market Size and Forecast, By Age Group
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Enteral Syringe Market
  - 7.5.8.1. Market Size and Forecast, By Type
  - 7.5.8.2. Market Size and Forecast, By Age Group
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Enteral Syringe Market
  - 7.5.9.1. Market Size and Forecast, By Type
  - 7.5.9.2. Market Size and Forecast, By Age Group
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

9.1. Fresenius SE And Co. KGaA
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
9.2. Boston Scientific Corporation
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
9.3. Danone
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
9.4. Cook Medical, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
9.5. Cardinal Health Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
9.6. Becton, Dickinson And Company
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
9.7. Moog Inc.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
9.8. B. Braun Melsungen AG
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
9.9. Owens And Minor, Inc.
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
9.10. Nestle S.A.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments